AI in Medicine News ・ ⚖️ Device approvals and regulation

Review Evaluates Open and Closed Artificial Intelligence Across Pharmaceutical Drug Development

Bioengineer.org · 11/11 08:05 UTC

A narrative review by pharmaceutical scientists outlines the practical trade-offs between open-source models and proprietary platforms. It covers five canonical stages of drug development.

Read the original (Bioengineer.org)

See it in the digest → ・ See this issue →